# Protein Satiety Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/protein-satiety-randomized-trial-evidence-review
Category: evidence-review
Summary: Protein Satiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are random
Last reviewed: 2026-06-25
Reviewed by: Migaku Evidence Review
# Protein Satiety Randomized Trial: What the Evidence Says

## Quick Answer

Protein Satiety Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study | randomized trial | 2 | 2026-06-11 | 10.1007/s00394-026-03971-3 |
| The Role of High-Protein Instant Ramen Noodles in Inducing and Maintaining Satiety: Acute, Randomized, Crossover Study | randomized trial | 2 | 2026-04-22 | 10.1038/s41387-026-00421-1 |

## What The Sources Report

- Elevated postprandial glucose levels are consistently associated with increased cardiovascular risk, even in normoglycaemic individuals. [Elbira Arig (2026); evidence level 2]
- Higher protein consumption above the RDA but within the AMDR has shown benefits, including the reduction of hunger, the increase of satiety, and the reduction of subsequent food intake which all together may contribute to the reduction of the risk of obesity. [Ozioma Princess U. (2026); evidence level 2]
- Strategies for treating and reducing the risk of obesity have therefore been our priority. [Ozioma Princess U. (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For protein satiety randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Elbira Arig (2026). Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. DOI: 10.1007/s00394-026-03971-3. PMCID: PMC13260030. PMID: 42274793. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13260030/
- Ozioma Princess U. (2026). The Role of High-Protein Instant Ramen Noodles in Inducing and Maintaining Satiety: Acute, Randomized, Crossover Study. DOI: 10.1038/s41387-026-00421-1. PMCID: PMC13237161. PMID: 42020359. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13237161/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.